NMTC today
$0.78+$0.00 (+0.54%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourLeaning Bullish
15 minDescending Triangle
5 minStrong Bearish
Daily trend turns up above $1.35
Key levels
Resistance$1.35
Resistance$1.04
Support$0.77
Latest news & SEC filings
ProductNeuroOne Reports Peer-Reviewed Publication on OneRF Trigeminal Nerve Ablation System
DealNeuroOne Lands Initial Pharma Buy for Its StereoCED System
All NMTC news →About NeuroOne Medical Technologies
NeuroOne Medical Technologies makes medical devices built on flexible, thin-film electrodes used to record, monitor, stimulate and ablate tissue in the brain and nervous system. Its cleared offerings include Evo cortical and sEEG electrodes for short-term brain monitoring and the OneRF ablation systems, including a trigeminal nerve version for pain. Zimmer Biomet distributes the Evo and OneRF brain products. Items still in development cover spinal cord stimulation, basivertebral nerve ablation and an electrode that delivers drugs while recording brain signals.
Based on the company's 10-K filed Dec 17, 2025.
Nasdaq · Healthcare
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
What Is the Price Target for NMTC?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is NMTC a Buy or Sell Right Now?
Thesis
- •Revenue growing 163.5% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NMTC.
Start Free Trial →Is NMTC Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$1.10
39
Moat Score
NONE
6/9
Piotroski Score
-3.5
Altman Z-Score
What Is Smart Money Doing with NMTC?
Insider Signal
SELLING
1 buys / 5 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Wambeke David J. | officer | Buy | 33,333 | $67K | Aug 27, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NMTC Growth Story
Revenue YoY
163.5%
3yr Revenue CAGR
276.0%
EPS Growth YoY
80.43%
FCF Growth YoY
73.8%
Revenue Trend
STRONG
Dark Pool Trades for NMTC
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NMTC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:36:51 | $0.80 | 1,299 | $$1K | BUY |
| 14:49:15 | $0.82 | 2,000 | $$2K | BUY |
| 14:30:08 | $0.75 | 1,400 | $$1K | SELL |
| 17:23:22 | $0.77 | 6,000 | $$5K | BUY |
| 16:17:04 | $0.83 | 5,000 | $$4K | BUY |
5 dark pool trades shown · $$13K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NMTC — frequently asked questions
What is NMTC stock price today?
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) is at $0.78, up 0.54% (+$0.00) at the Nov 11, 2026 close.
Why is NMTC stock moving today?
Latest NMTC news — Oct 30, 2026: NeuroOne Reports Peer-Reviewed Publication on OneRF Trigeminal Nerve Ablation System · Oct 22, 2026: NeuroOne Lands Initial Pharma Buy for Its StereoCED System
What do analysts rate NMTC?
Analyst ratings for NMTC: 3 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did NMTC beat earnings?
NMTC last reported on Aug 13, 2026: EPS -$0.23 vs -$0.21 expected — a miss of 9.5%.
Does NMTC pay a dividend?
NMTC does not currently pay a dividend.
What are NMTC support and resistance levels?
Support: $0.77. Resistance: $1.04, $1.35, $1.57.
What are insiders doing with NMTC?
Insider activity: SELLING, 1 buys and 5 sells in the last 90 days.
What is the latest news on NMTC?
Oct 30, 2026: NeuroOne Reports Peer-Reviewed Publication on OneRF Trigeminal Nerve Ablation System · Oct 22, 2026: NeuroOne Lands Initial Pharma Buy for Its StereoCED System